Mellar P Davis. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Administration, IntranasalAnalgesics, Opioid/administration & dosageAnalgesics, Opioid/economicsAnalgesics, Opioid/therapeutic useBreakthrough Pain/drug therapyCost-Benefit AnalysisFentanyl/administration & dosageFentanyl/economicsFentanyl/therapeutic useHumansOxycodone/economicsOxycodone/therapeutic useRisk Reduction Behavior
Substances： See more » Analgesics, OpioidOxycodoneFentanyl
Year: 2012 PMID： 22939453 DOI： 10.1016/j.jpainsymman.2012.06.002
Source DB: PubMed Journal: J Pain Symptom Manage ISSN： 0885-3924 Impact factor: 3.612